Frank X Leonard Novo Cure LTD (NVCR) insider trading activity

Frank X Leonard is EVP, Pres., Novocure Oncology of NovoCure Ltd. Currently has a direct ownership of 161,834 shares of NVCR, which is worth approximately $2.46 Million. The most recent transaction as insider was on Jun 28, 2024, when has been sold 1,736 shares (Ordinary Shares) at a price of $12.24 per share, resulting in proceeds of $21,248. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K

0% 3M change

198.12% 12M change

Total Value Held $2.46 Million

Frank X Leonard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 28 2024	BUY Grant, award, or other acquisition	$21,248 $12.24 p/Share	1,736 Added 1.06%	161,834 Ordinary Shares
Mar 04 2024	SELL Open market or private sale	$13,448 $16.01 p/Share	840 Reduced 0.52%	160,098 Ordinary Shares
Mar 01 2024	SELL Open market or private sale	$26,914 $16.03 p/Share	1,679 Reduced 1.03%	160,938 Ordinary Shares
Feb 28 2024	SELL Open market or private sale	$33,538 $16.14 p/Share	2,078 Reduced 1.26%	162,617 Ordinary Shares
Feb 27 2024	BUY Grant, award, or other acquisition	$1,666,658 $16.3 p/Share	102,249 Added 38.3%	164,695 Ordinary Shares
Mar 07 2023	SELL Open market or private sale	$626,262 $75.29 p/Share	8,318 Reduced 13.29%	54,284 Ordinary Shares
Mar 03 2023	SELL Open market or private sale	$402,962 $76.16 p/Share	5,291 Reduced 7.79%	62,602 Ordinary Shares
Mar 03 2023	SELL Open market or private sale	$159,860 $77.64 p/Share	2,059 Reduced 2.94%	67,893 Ordinary Shares
Mar 03 2023	BUY Grant, award, or other acquisition	-	11,808 Added 14.44%	69,952 Ordinary Shares
Mar 02 2023	SELL Open market or private sale	$63,536 $75.28 p/Share	844 Reduced 1.43%	58,144 Ordinary Shares
Mar 02 2023	SELL Open market or private sale	$310,858 $75.69 p/Share	4,107 Reduced 6.51%	58,988 Ordinary Shares
Mar 01 2023	SELL Open market or private sale	$128,590 $76.36 p/Share	1,684 Reduced 2.6%	63,095 Ordinary Shares
Feb 28 2023	BUY Grant, award, or other acquisition	-	18,621 Added 22.33%	64,779 Ordinary Shares
Jan 05 2023	SELL Open market or private sale	$4,464,291 $113.0 p/Share	39,507 Reduced 46.12%	46,158 Ordinary Shares
Jan 05 2023	BUY Exercise of conversion of derivative security	$530,247 $15.06 p/Share	35,209 Added 39.76%	53,341 Ordinary Shares
Nov 01 2022	BUY Grant, award, or other acquisition	-	6,830 Added 11.92%	50,456 Ordinary Shares
Oct 13 2022	SELL Open market or private sale	$513,372 $76.01 p/Share	6,754 Reduced 13.41%	43,626 Ordinary Shares
Oct 06 2022	SELL Open market or private sale	$569,835 $84.37 p/Share	6,754 Reduced 11.82%	50,380 Ordinary Shares
Sep 29 2022	SELL Open market or private sale	$522,422 $77.35 p/Share	6,754 Reduced 10.57%	57,134 Ordinary Shares
Sep 22 2022	SELL Open market or private sale	$520,058 $77.0 p/Share	6,754 Reduced 9.56%	63,888 Ordinary Shares
Sep 15 2022	SELL Open market or private sale	$1,087,824 $88.65 p/Share	12,271 Reduced 14.8%	70,642 Ordinary Shares
Sep 15 2022	BUY Exercise of conversion of derivative security	$39,447 $7.15 p/Share	5,517 Added 6.24%	82,913 Ordinary Shares
Sep 09 2022	SELL Open market or private sale	$163,944 $88.0 p/Share	1,863 Reduced 2.17%	84,150 Ordinary Shares
Sep 06 2022	SELL Open market or private sale	$108,741 $78.57 p/Share	1,384 Reduced 1.58%	86,013 Ordinary Shares
Sep 02 2022	SELL Open market or private sale	$46,159 $79.04 p/Share	584 Reduced 0.66%	87,397 Ordinary Shares

FXL

Frank X Leonard

EVP, Pres., Novocure Oncology

Malvern, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Value

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NovoCure Ltd

Track Activities on NVCR

Account